News Insight - August 3ʳᵈ

Vaccine Race: Who Will Recover from Covid-19 First?

Nobel winning biologist Joshua Lederberg once stated that “The single biggest threat to man’s continued dominance on the planet is the virus.” But for a long time, scientists had believed that the upcoming threat would be because of influenza viruses. So accordingly, the pharmaceutical industry was prepared for that type of viruses. Influenza, known as flu, was well known and some countries had sleeping contracts for possible treatments when the 2009 ‘bird flu’ pandemic hit the world. However, nobody had foreseen that the next pandemic would come from coronavirus; hence nobody signed a contract nor researched for coronavirus vaccine. Yet, companies have acted quickly and are now in competition with each other in the so-called ‘COVID-19 vaccine race.’

—  Begüm GÜVEN

Editor's Note

Hello Everyone,

We have good news, great news, and excellent articles this month! First, the good news is that we added a section called ‘About’ to explain our section names and the contents of the sections. Moving on to the great news, we had more time to put on our articles since all of our authors are college students and the spring term has finished. So, we doubled the number of articles in some sections, even tripled the articles in the Present and Voting section. Finally, our excellent articles are waiting for you!

 

During the period that we prepared our fifth issue, we continued to experience and learn from the environment we live in. As our issue counts increase, our political views and interests keep evolving and we try to keep the subjects of our articles diversified. Distracting ourselves from the bad news and looking for entertainment are crucial elements to keep ourselves together. We totally value this side of the content-consuming and prepared a number of articles in our Intersection, Online, Trivial, and Present and Chill sections for this manner. To continue with the serious matters, usually, we tend to focus on the bigger picture and examine the world’s ongoing problems, but we made an exception to look at the growing number of femicides issue in Turkey in this issue. One of the editors of the third issue, Nilay Şebnem YAREN wrote an opinion essay on Sexism and Gender-Based Crimes in Present and Voting. As the editors of this issue, we analyzed the past and the present of Feminism in Universal. Of course, we did not forget about the pandemic and its ongoing effects in our lives, you can find COVID related articles in Agenda of the Month and Spotlight. As usual, we have plenty of articles on today’s politics and historical backgrounds of current events. Do not forget to check out the rest of the sections, otherwise, you will miss so much of the good work!

 

Before we finish, we would like to hear more of your opinion about PRESENT, so please take a few minutes to fill out our Reader Feedback Form in the Feedback section. We value your opinion and are grateful for your interest. As we continue improving our work, the readers’ input is priceless. Monday is still our day and Weekly News Insights are keep coming, do not forget to check the articles out!

 

Until next time, wear your mask and protect the city!

 

Hülya AFAT & Didem ÖZÇAKIR

Editors of This Issue

Articles

PRESENT is a non-profit monthly bulletin published by the Model United Nations Subcommittee of Boğaziçi University Debating Society (BUDS) on the first Monday of every month. 
 
Articles in the issues of PRESENT do not reflect the views of Boğaziçi University or BUDS. Opinions belong solely to the author(s). All pictures copyright to their respective owner(s). PRESENT does not claim ownership of any of the pictures displayed on this bulletin. All images are used for noncommercial and educational purposes. If any images posted here are in violation of copyright law, please contact us and we will gladly remove the offending images immediately.

  • Beyaz Instagram Simge
  • Beyaz Facebook Simge
  • Beyaz Heyecan Simge

© by Boğaziçi MUN 

© 2020. This work is licensed under a CC BY-NC-SA 4.0 license.